Skip to main content

Advertisement

SpringerLink
Log in

Association between human papillomavirus and oral cancer: a literature review

  • Invited Review Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

HPV plays a vital role in the development of cervical cancers and oropharyngeal cancers, but it is controversial whether HPV is involved in oral cancer development and to what extent. In this review, the clinical characteristics, diagnosis, treatment, and prognosis of HPV-positive oral cancers are summarized, and the mechanisms of HPV-related oral cancer development are discussed. HPV DNA positivity rates are 20–30% in oral squamous cell carcinoma (OSCC), and HPV16 is the most common high-risk HPV. E6/E7 mRNA positivity rates are 2–6% in OSCC. Detection of both high-risk HPV DNA and E6/E7 mRNA is recommended to determine the presence of active HPV, in agreement with high-risk HPV infection in OSCC. Surgical treatment is the first-line therapy for HPV-positive and -negative oral cancer, but there is no unified view about the prognosis of HPV-positive OSCC patients. HPV16 may play a vital role in malignant transformation in oral epithelial dysplasia, and a model of synergistic carcinogenic impact of HPV and tobacco smoking is predicted. Additionally, it is hypothesized that there are different HPV-associated oral cancers, such as integrated HPV DNA-positive OSCC with stable E6/E7 expression and episomal HPV DNA-positive OSCC. In summary, the role of HPV in oral carcinogenesis seems to be limited because of the low E6/E7 positivity in OSCCs; however, episomal HPV DNA may play a vital role in the malignant transformation of HPV-positive oral premalignant lesions. Further investigation is required to promote new insights into the role of episomal HPV DNA in oral carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424

    PubMed  Google Scholar 

  2. Ferlay J, Ervik M, Lam F, et al. (2018) Global cancer observatory: cancer today. International Agency for Research on Cancer, Lyon. Available via DIALOG. https://gco.iarc.fr/today

  3. Hussein AA, Helder MN, de Visscher JG et al (2017) Global incidence of oral and oropharynx cancer in patients younger than 45 years versus older patients: a systematic review. Eur J Cancer 82:115–127

    PubMed  Google Scholar 

  4. Projected Cancer Statistics. Projected cancer incidence in 2022. ganjoho.jp. Available via DIALOG. https://ganjoho.jp/reg_stat/statistics/stat/short_pred_en.html

  5. Kawakita D, Oze I, Iwasaki S et al (2022) Trends in the incidence of head and neck cancer by subsite between 1993 and 2015 in Japan. Cancer Med 11:1553–1560

    PubMed  PubMed Central  Google Scholar 

  6. Morikawa T, Futoo E, Funakoshi A et al (2016) Clinical statistical study of oral cancer in young patients during 25 years in our department (in Japanese). Jpn J Oral Maxillofac Surg 62:144–150

    Google Scholar 

  7. Gholizadeh P, Eslami H, Yousefi M et al (2016) Role of oral microbiome on oral cancers, a review. Biomed Pharmacother 84:552–558

    CAS  PubMed  Google Scholar 

  8. Foy JP, Bertolus C, Boutolleau D et al (2020) Arguments to support a viral origin of oral squamous cell carcinoma in non-smoker and non-drinker patients. Front Oncol 10:822

    PubMed  PubMed Central  Google Scholar 

  9. Doorbar J, Quint W, Banks L et al (2012) The biology and life-cycle of human papillomaviruses. Vaccine 30(Suppl 5):F55-70

    CAS  PubMed  Google Scholar 

  10. Gillison ML, Broutian T, Pickard RKL et al (2012) Prevalence of oral HPV infection in the United States, 2009–2010. JAMA 307:693–703

    CAS  PubMed  PubMed Central  Google Scholar 

  11. D’Souza G, Cullen K, Bowie J et al (2014) Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection. PLoS One 9:e86023

    PubMed  PubMed Central  Google Scholar 

  12. Giraldi L, Collatuzzo G, Hashim D et al (2021) Infection with human papilloma virus (HPV) and risk of subsites within the oral cancer. Cancer Epidemiol 75:102020

    PubMed  Google Scholar 

  13. Ndiaye C, Mena M, Alemany L et al (2014) HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 15:1319–1331

    CAS  PubMed  Google Scholar 

  14. Kansy K, Thiele O, Freier K (2014) The role of human papillomavirus in oral squamous cell carcinoma: myth and reality. Oral Maxillofac Surg 18:165–172

    PubMed  Google Scholar 

  15. Li H, Park HS, Osborn HA et al (2018) Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas. Cancers Head Neck 3:4

    PubMed  PubMed Central  Google Scholar 

  16. Lingen MW, Xiao W, Schmitt A et al (2013) Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas. Oral Oncol 49:1–8

    PubMed  Google Scholar 

  17. Nauta IH, Heideman DAM, Brink A et al (2021) The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma. Int J Cancer 149:420–430

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Lewis JS Jr, Smith MH, Wang X et al (2022) Human papillomavirus-associated oral cavity squamous cell carcinoma: an entity with distinct morphologic and clinical features. Head Neck Pathol. https://doi.org/10.1007/s12105-022-01467-0

    Article  PubMed  PubMed Central  Google Scholar 

  19. Rooper LM, Windon MJ, Hernandez T et al (2020) HPV-positive squamous cell carcinoma of the larynx, oral cavity, and hypopharynx: clinicopathologic characterization with recognition of a novel warty variant. Am J Surg Pathol 44:691–702

    PubMed  PubMed Central  Google Scholar 

  20. Yilmaz E, Ozbun MA, Gan GN et al (2021) Molecular and immune signature of HPV-positive oral cavity squamous cell carcinoma. Oral Oncol 116:105175

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Gillison ML, Akagi K, Xiao W et al (2019) Human papillomavirus and the landscape of secondary genetic alterations in oral cancers. Genome Res 29:1–17

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Durzynska J, Lesniewicz K, Poreba E (2017) Human papillomaviruses in epigenetic regulations. Mutat Res Rev Mutat Res 772:36–50

    CAS  PubMed  Google Scholar 

  23. van Kempen PM, Noorlag R, Braunius WW et al (2014) Differences in methylation profiles between HPV-positive and HPV-negative oropharynx squamous cell carcinoma: a systematic review. Epigenetics 9:194–203

    PubMed  Google Scholar 

  24. Reis RSD, Santos JAD, Abreu PM et al (2020) Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma. Genet Mol Biol 43:e20190334

    PubMed  PubMed Central  Google Scholar 

  25. Prawdzic Seńkowska A, Kiczmer P et al (2019) Impact of HPV infection on gene expression and methylation in oral cancer patients. J Med Microbiol 68:440–445

    PubMed  Google Scholar 

  26. Worsham MJ, Chen KM, Ghanem T et al (2013) Epigenetic modulation of signal transduction pathways in HPV-associated HNSCC. Otolaryngol Head Neck Surg 149:409–416

    PubMed  PubMed Central  Google Scholar 

  27. Lechner M, Liu J, Masterson L et al (2022) HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nat Rev Clin Oncol 19:306–327

    PubMed  PubMed Central  Google Scholar 

  28. Japan Society of Clinical Oncology (2019) Clinical practice guidelines. jsco-cpg.jp.

  29. Elango KJ, Suresh A, Erode EM et al (2011) Role of human papilloma virus in oral tongue squamous cell carcinoma. Asian Pac J Cancer Prev 12:889–896

    PubMed  Google Scholar 

  30. Komolmalai N, Pongsiriwet S, Lertprasertsuke N et al (2020) Human papillomavirus 16 and 18 infection in oral cancer in Thailand: a multicenter study. Asian Pac J Cancer Prev 21:3349–3355

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Isayeva T, Xu J, Ragin C et al (2015) The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathways. Mod Pathol 28:631–653

    CAS  PubMed  Google Scholar 

  32. Maeda K, Suzuki T, Ooyama Y et al (2010) Colorimetric analysis of unstained lesions surrounding oral squamous cell carcinomas and oral potentially malignant disorders using iodine. Int J Oral Maxillofac Surg 39:486–492

    CAS  PubMed  Google Scholar 

  33. Ansarin M, Bruschini R, Navach V et al (2019) Classification of GLOSSECTOMIES: proposal for tongue cancer resections. Head Neck 41:821–827

    PubMed  PubMed Central  Google Scholar 

  34. Yoshino T, Hasegawa Y, Takahashi S et al (2013) Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial. Jpn J Clin Oncol 43:524–531

    PubMed  PubMed Central  Google Scholar 

  35. Motai R, Sawabe M, Kadowaki S et al (2021) Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma. Int J Clin Oncol 26:1188–1195

    CAS  PubMed  Google Scholar 

  36. Chen L, Mo DC, Hu M et al (2022) PD-1/PD-L1 inhibitor monotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck: a meta-analysis. Am J Otolaryngol 43:103324

    CAS  PubMed  Google Scholar 

  37. Ferris RL, Blumenschen G, Fayette J et al (2016) Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med 375:1856–1867

    PubMed  PubMed Central  Google Scholar 

  38. Yamakawa N, Umeda M, Yoshii Y et al (2022) Multicenter retrospective study of nivolumab for recurrent/metastatic oral squamous cell carcinoma. Oral Dis. https://doi.org/10.1111/odi.14471

    Article  PubMed  Google Scholar 

  39. Quayle SN, Girgis N, Thapa DR et al (2020) CUE-101, a novel E7-pHLA-IL2-Fc fusion protein, enhances tumor antigen-specific T-cell activation for the treatment of HPV16-driven malignancies. Clin Cancer Res 26:1953–1964

    CAS  PubMed  Google Scholar 

  40. Nagarsheth NB, Norberg SM, Sinkoe AL et al (2021) TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers. Nat Med 27:419–425

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Sugiyama M, Bhawal UK, Kawamura M et al (2007) Human papillomavirus-16 in oral squamous cell carcinoma: clinical correlates and 5-year survival. Br J Oral Maxillofac Surg 45:116–122

    PubMed  Google Scholar 

  42. Pérez-Islas E, García-Carrancá A, Acosta-Gio E et al (2022) Prognostic importance of DNA from human papillomavirus in patients with oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal 27:e150–e158

    PubMed  PubMed Central  Google Scholar 

  43. Christianto S, Li KY, Huang TH et al (2022) The prognostic value of human papilloma virus infection in oral cavity squamous cell carcinoma: a meta-analysis. Laryngoscope S132:1760–1770

    Google Scholar 

  44. Nulton TJ, Kim NK, DiNardo LJ et al (2018) Patients with integrated HPV16 in head and neck cancer show poor survival. Oral Oncol 80:52–55

    PubMed  PubMed Central  Google Scholar 

  45. Shigeishi H, Sugiyama M (2016) Risk factors for oral human papillomavirus infection in healthy individuals: a systematic review and meta-analysis. J Clin Med Res 8:721–729

    CAS  PubMed  PubMed Central  Google Scholar 

  46. Holway GV, Hernandez SM (2018) Oral sex and condom use in a U.S. national sample of adolescents and young adults. J Adolesc Health 62:402–410

    PubMed  Google Scholar 

  47. Hanley SJ, Yoshioka E, Ito Y et al (2015) HPV vaccination crisis in Japan. Lancet 385:2571

    PubMed  Google Scholar 

  48. Barbour SE, Nakashima K, Zhang JB et al (1997) Tobacco and smoking: environmental factors that modify the host response (immune system) and have an impact on periodontal health. Crit Rev Oral Biol Med 8:437–460

    CAS  PubMed  Google Scholar 

  49. Yanagita M, Kobayashi R, Kojima Y et al (2012) Nicotine modulates the immunological function of dendritic cells through peroxisome proliferator-activated receptor-γ upregulation. Cell Immunol 274:26–33

    CAS  PubMed  Google Scholar 

  50. Dalla Torre D, Burtscher D, Sölder E et al (2019) The correlation between the quality of oral hygiene and oral HPV infection in adults: a prospective cross-sectional study. Clin Oral Investig 23:179–185

    PubMed  Google Scholar 

  51. Toyama K, Maeda H, Sugita Y et al (2008) A research of the state of oral hygiene, lifestyle and human papillomavirus premlence among senior high school students (in Japanese). Tokai J School Health 32:3–12

    Google Scholar 

  52. Shigeishi H, Murodumi H, Ohta K et al (2021) Detection of HPV16 E6 DNA in periodontal pockets of middle-aged and older people. Oral Sci Int 18:50–55

    Google Scholar 

  53. Ortiz AP, González D, Vivaldi-Oliver J et al (2018) Periodontitis and oral human papillomavirus infection among Hispanic adults. Papillomavirus Res 5:128–133

    PubMed  PubMed Central  Google Scholar 

  54. Shigeishi H, Sugiyama M, Ohta K (2021) Relationship between the prevalence of oral human papillomavirus DNA and periodontal disease (review). Biomed Rep 14:40

    CAS  PubMed  PubMed Central  Google Scholar 

  55. Saini R, Osman NB, Ismail M et al (2011) Association of human papillomavirus with denture wearing. J Investig Clin Dent 2:241–247

    PubMed  Google Scholar 

  56. Nishimura Y, Maeda H, Hattori M et al (2004) Human papillomavirus infection in the oral cavity of denture wearers (in Japanese). Nihon Hotetsu Shika Gakkai Zasshi 48:713–722

    PubMed  Google Scholar 

  57. Nascimento ACDS, Nocetti MC, Lugo LZA et al (2019) Oncogenic high-risk human papillomavirus in patients with full denture. Braz Oral Res 33:e091

    PubMed  Google Scholar 

  58. Pindborg JJ, Reichart PA, Smith CJ, et al. (1997) Histological typing of cancer and precancer of the oral mucosa, 2nd edn. World Health Organization International Classification of Tumours. Springer Verlag, Berlin, p 21–31

  59. Lerman MA, Almazrooa S, Lindeman N et al (2017) HPV-16 in a distinct subset of oral epithelial dysplasia. Mod Pathol 30:1646–1654

    PubMed  Google Scholar 

  60. Odell E, Kujan O, Warnakulasuriya S et al (2021) Oral epithelial dysplasia: recognition, grading and clinical significance. Oral Dis 27:1947–1976

    PubMed  Google Scholar 

  61. Syrjänen S, Lodi G, von Bültzingslöwen I et al (2011) Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 17(Suppl 1):58–72

    PubMed  Google Scholar 

  62. Khanal S, Trainor PJ, Zahin M et al (2017) Histologic variation in high grade oral epithelial dysplasia when associated with high-risk human papillomavirus. Oral Surg Oral Med Oral Pathol Oral Radiol 123:566–585

    PubMed  Google Scholar 

  63. Sugiyama M, Bhawal UK, Dohmen T et al (2003) Detection of human papillomavirus-16 and HPV-18 DNA in normal, dysplastic, and malignant oral epithelium. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:594–600

    PubMed  Google Scholar 

  64. Wei L, Griego AM, Chu M et al (2014) Tobacco exposure results in increased E6 and E7 oncogene expression, DNA damage and mutation rates in cells maintaining episomal human papillomavirus 16 genomes. Carcinogenesis 35:2373–2381

    CAS  PubMed  PubMed Central  Google Scholar 

  65. Su SC, Chang LC, Huang HD et al (2021) Oral microbial dysbiosis and its performance in predicting oral cancer. Carcinogenesis 42:127–135

    CAS  PubMed  Google Scholar 

  66. Whitmore SE, Lamont RJ (2014) Oral bacteria and cancer. PLoS Pathog 10:e1003933

    PubMed  PubMed Central  Google Scholar 

  67. Olthof NC, Speel EJ, Kolligs J et al (2014) Comprehensive analysis of HPV16 integration in OSCC reveals no significant impact of physical status on viral oncogene and virally disrupted human gene expression. PLoS One 9:e88718

    PubMed  PubMed Central  Google Scholar 

  68. Olthof NC, Huebbers CU, Kolligs J et al (2015) Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines. Int J Cancer 136:E207–E218

    CAS  PubMed  Google Scholar 

  69. Gray E, Pett MR, Ward D et al (2010) In vitro progression of human papillomavirus 16 episome-associated cervical neoplasia displays fundamental similarities to integrant-associated carcinogenesis. Cancer Res 70:4081–4091

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

No funding.

Author information

Authors and Affiliations

  1. Department of Public Oral Health, Program of Oral Health Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8553, Japan

    Hideo Shigeishi

Authors
  1. Hideo Shigeishi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hideo Shigeishi.

Ethics declarations

Conflict of interest

The authors have no competing interests to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shigeishi, H. Association between human papillomavirus and oral cancer: a literature review. Int J Clin Oncol 28, 982–989 (2023). https://doi.org/10.1007/s10147-023-02327-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-023-02327-9

Keywords

Search

Navigation